Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

DropMicS

Financiado

Droplet printable microfluidic arrays for high-throughput screening of 3D cell c...

This project will develop high-throughput 3D cell culture devices with perfusion by interfacing microfluidics and droplet printing technologies and subsequently applying them to model neuro-development disorders. For decades, 2D c... ver más

31/05/2026

ESPCI Paris

196K€

Presupuesto del proyecto: 196K€

Líder del proyecto

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDU... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-20

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023

I+D

Cerrada hace 1 año

0% 100%

3 Participantes

ESPCI Paris

195.91K€ | Lider

INSERM

N.D. | Participante

Proyectos interesantes

uBeat Mimic human complexity in a Beat to revolutionize the drug d... 75K€ Cerrado

GALILEO The first wide range flow sensor to unlock microfluidic cell... 2M€ Cerrado

PID2021-122409OB-C22 ANALISIS CUANTITATIVO DE ORGANOIDES DERIVADOS DE PACIENTES D... 145K€ Cerrado

SYNEBIO High-throughput combinatory drugs testing on in vitro 3D cel... 150K€ Cerrado

PTQ-16-08396 Bone-on-Chip Analysis Platform for In vitro Drug Performance... 84K€ Cerrado

CPP2021-008396 SISTEMA MICROFLUIDICO PARA APLICACIONES EN TEJIDO EN UN CHIP 378K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 26 meses Fecha Inicio: 2024-03-20
Fecha Fin: 2026-05-31

Presupuesto del proyecto 196K€

Descripción del proyecto This project will develop high-throughput 3D cell culture devices with perfusion by interfacing microfluidics and droplet printing technologies and subsequently applying them to model neuro-development disorders. For decades, 2D cell culture followed by animal testing has been the standard for therapeutic drug discovery. 3D systems have the potential to recreate more faithful physiological conditions (cell interactions, gradients, perfusion, flow). Thus, they are expected to be more predictive for efficacy and toxicity than 2D systems and minimize the use of animals. However, there is currently no 3D model which enables high-throughput (HT) and perfusion at once: spheroids and organoids in plates can be HT but without perfusion, pressure-driven microfluidics has perfusion but is not HT, droplet microfluidics is HT but cannot handle large drug libraries and has no perfusion. Here, we will leverage the physics of wetting and capillarity to design chamber arrays with liquid-trapping geometries, which can be entirely operated by external droplet injection. We will set up designs and protocols for the embedding of cells in 3D hydrogel matrices and submit them to perfusion of medium and drug, including uniform or gradient conditions in each chamber. We will demonstrate the HT interfacing with droplet printers. Finally, we will apply the device to screen compounds and monitor the modulation of microglia (the immune cell of the brain) inflammation that affects the lives of >2 million preterm babies every year.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores